Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sopharma AD Director's Dealing 2020

Sep 2, 2020

2543_rns_2020-09-02_cbea7d8a-5dee-45c4-86d2-109cad9a13ff.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Current report №78 / 2020 Dated 02.09.2020

NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014

Sopharma AD (the "Company") announces that pursuant to art. 3, para 26a and art. 19, para 1a from Regulation 596/2014 of the European Parliament and of the Council, it was notified by Mrs Rositsa Doneva, person closely associated with Mr Ognian Donev, Chairman of the Board of Directors that she, executed the following transactions related to shares in the Company:

Date of the Operation Number of Unit price
transaction shares (BGN)
01.09.2020 Buy 1000 3,12

The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade.

Signatures of individuals authorized to represent the Company:

Ognian Donev